Purging in autologous and allogeneic bone marrow transplantation.

Abstract

The success of hematoablative dosages of cytotoxic therapy followed by stem cell transplantation depends on the disease response to the intensive drug dose and the ability of the transplant to provide durable hematopoietic reconstitution. In autologous stem cell transplantation, patients' own bone marrow or peripheral blood is used for hematopoietic… (More)

Topics

  • Presentations referencing similar topics